Biological Information

Background Information:

The PathHunter® Bevacizumab Bioassay kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay assesses VEGFA-induced dimerization of VEGFR2 receptors. The included cells overexpress VEGFR2 target protein fused to PK alongside VEGFR2 target protein fused to EA. Upon ligand-induced dimerization of VEGFR2, detectable EFC signal is produced. This assay has been optimized and qualified with Avastin® (not supplied in the bioassay kit). Avastin® is a registered trademark of Genentech, Inc. Bioassay kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, control agonist, detection reagent, and assay plates.

Please reach out to Tech Support at DiscoverXSupportUS@discovery.eurofinsus.com for lot specific CoA.

Target Class:

Kinase

Family:

RTK

Sub Family:

Protein Tyrosine

Protein Name:

KDR (VEGFR2)

Protein Aliases:

vascular endothelial growth factor receptor 2|fetal liver kinase 1

Accession Number:

NM_002253.2

UniProt Number:

P35968

Gene Name:

KDR

Gene ID:

3791

Gene Aliases:

FLK1|VEGFR|VEGFR2|CD309

Target Species:

Human

Cell Background:

HEK293

Usage

Product Type:

Bioassay Kits

Application:

Potency, Commercial Release & Stability

Kit Components:

KitComponent

Storage Conditions:

Store in vapor phase of liquid nitrogen.

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Cell Based, Qualified

Assay Measures:

Dimerization

Detection Method:

Chemiluminescence

Bioassay Data

INN Drug Name:

Bevacizumab

Qualified With:

Avastin®

Trademark Statement:

Avastin® is a registered trademark of Genentech, Inc.

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

PathHunter®